United States Pharmaceuticals

Elite Pharmaceuticals, Inc. (ELTP)

Track

Track

Elite Pharmaceuticals experienced two recent buy transactions totaling 17,220 dollars by Barry H. Dash. This activity occurs amid a 36.1 percent decline in stock value over the past quarter. No recent results financiers were reported, and the equity currently trades near its fifty-two-week low.
Ticker: ELTP Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Elite Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Dash Barry H Non-Executive Director
Transaction date
Purchase
Price
334.41
Quantity 99,877 -27.1%
Value US$4,358,191
Dash Barry H Non-Executive Director
Transaction date
Purchase
Price
362.36
Quantity 14,856 -46.0%
Value US$3,383,776
2.7
Plassche Douglas EVP Operations Officer
Transaction date
Sale
Price
287.48
Quantity 76,121 +19.4%
Value US$2,606,307
2.7
Plassche Douglas Officer Officer
Transaction date
Proposed sale
Price
5.55
Quantity 100,000
Value US$555,000
2.2
Kirkov Kirko Chief Commercial Officer Officer
Transaction date
Purchase
Price
0.59
Quantity 16,366 +inf%
Value US$9,640
2.7
Plassche Douglas EVP Operations Officer
Transaction date
Sale
Price
0.58
Quantity 200,000 -8.0%
Value US$115,800
2.7
Plassche Douglas Officer Officer
Transaction date
Proposed sale
Price
0.61
Quantity 500,000
Value US$303,000
2.7
Plassche Douglas SVP of Operations Officer
Transaction date
Sale
Price
0.51
Quantity 333,932 -100.0%
Value US$170,305
2.7
Plassche Douglas SVP of Operations Officer
Transaction date
Sale
Price
0.49
Quantity 800,000 -70.6%
Value US$392,000
2.7
Plassche Douglas Officer Officer
Transaction date
Proposed sale
Price
0.60
Quantity 1,133,932
Value US$680,359
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.34
Quantity 258,090 -3.3%
Value US$88,267
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.35
Quantity 312,430 -3.8%
Value US$107,788
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.31
Quantity 100,456 -1.2%
Value US$31,141
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.32
Quantity 100,000 -1.2%
Value US$32,090
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.31
Quantity 50,000 -0.6%
Value US$15,580
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.33
Quantity 24,400 -0.3%
Value US$8,052
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.32
Quantity 349,660 -4.0%
Value US$111,891
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.33
Quantity 45,518 -0.5%
Value US$15,021
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.33
Quantity 13,000 -0.1%
Value US$4,290
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.34
Quantity 312,300 -3.4%
Value US$106,182
TREPPEL JERRY former Chairman
Transaction date
Sale
Price
0.35
Quantity 115,000 -1.3%
Value US$40,250
TREPPEL JERRY Chairman of Board Executive Director
Transaction date
Sale
Price
0.31
Quantity 25,000 -0.3%
Value US$7,625
TREPPEL JERRY Chairman of Board Executive Director
Transaction date
Sale
Price
0.30
Quantity 25,000 -0.3%
Value US$7,502
TREPPEL JERRY Chairman of Board Executive Director
Transaction date
Sale
Price
0.30
Quantity 50,000 -0.5%
Value US$15,125
TREPPEL JERRY Chairman of Board Executive Director
Transaction date
Sale
Price
0.30
Quantity 50,000 -0.5%
Value US$15,000
Plassche Douglas Executive VP of Operations Officer
Transaction date
Sale
Price
0.24
Quantity 85,530 -53.9%
Value US$20,168
Hakim Nasrat A CEO & President Executive Director
Transaction date
Purchase
Price
0.31
Quantity 265,500 +10.9%
Value US$82,385
Hakim Nasrat A CEO & President Executive Director
Transaction date
Purchase
Price
0.31
Quantity 434,500 +21.7%
Value US$133,956
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.38
Quantity 329,437 -5.6%
Value US$125,944
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.41
Quantity 147,664 -2.5%
Value US$60,542
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.43
Quantity 190,172 -3.1%
Value US$81,165
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.60
Quantity 239,367 -1.2%
Value US$144,003
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.60
Quantity 239,367 -0.4%
Value US$144,003
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.60
Quantity 239,367 -1.6%
Value US$144,003
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.60
Quantity 239,367 -0.4%
Value US$144,003
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.68
Quantity 1,051,450 -6.6%
Value US$714,986
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.68
Quantity 1,051,450 -4.9%
Value US$714,986
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.68
Quantity 1,051,450 -1.5%
Value US$714,986
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.68
Quantity 1,051,450 -1.5%
Value US$714,986
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.90
Quantity 773,050 -4.8%
Value US$692,344
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.90
Quantity 773,050 -3.6%
Value US$692,344
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.90
Quantity 773,050 -1.1%
Value US$692,344
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.90
Quantity 773,050 -1.1%
Value US$692,344
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.18
Quantity 805,583 -1.1%
Value US$147,422
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.18
Quantity 805,583 -5.0%
Value US$147,422
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.18
Quantity 805,583 -3.7%
Value US$147,422
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.18
Quantity 805,538 -1.1%
Value US$147,413
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.13
Quantity 275,000 -0.4%
Value US$34,512
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.13
Quantity 275,000 -0.4%
Value US$34,512
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.13
Quantity 275,000 -1.7%
Value US$34,512
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.13
Quantity 275,000 -1.3%
Value US$34,512
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.13
Quantity 100,000 -0.1%
Value US$12,520
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.13
Quantity 100,000 -0.1%
Value US$12,520
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.13
Quantity 100,000 -0.5%
Value US$12,520
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 25,000 -0.0%
Value US$3,030
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 25,000 -0.1%
Value US$3,030
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 25,000 -0.2%
Value US$3,030
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 25,000 -0.0%
Value US$3,030
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 23,626 -0.0%
Value US$2,793
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 23,626 -0.0%
Value US$2,793
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 23,626 -0.2%
Value US$2,793
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 23,626 -0.1%
Value US$2,793
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 357,000 -0.5%
Value US$43,126
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 357,000 -1.6%
Value US$43,126
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 357,000 -2.2%
Value US$43,126
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 357,000 -0.5%
Value US$43,126
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 21,000 -0.0%
Value US$2,457
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 21,000 -0.1%
Value US$2,499
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 21,000 -0.1%
Value US$2,457
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 21,000 -0.0%
Value US$2,457
EPIC INVESTMENTS, LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 1,170,000 -1.6%
Value US$137,475
NARINE JEENARINE Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 1,170,000 -6.9%
Value US$137,475
NIGALAYE ASHOK G Chief Scientific Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.12
Quantity 1,170,000 -5.1%
Value US$137,475
EPIC PHARMA LLC Large shareholder
Transaction date
Sale
Price
0.12
Quantity 1,170,000 -1.6%
Value US$137,475
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-08-19 B Purchase
Dash Barry H
Non-Executive Director
99,877 -27.1%
334.41
US$4,358,191 		99,877 -27.1% 334.41 US$4,358,191
2026-09-10 2026-08-19 B Purchase
Dash Barry H
Non-Executive Director
14,856 -46.0%
362.36
US$3,383,776 		14,856 -46.0% 362.36 US$3,383,776
2025-10-03 2025-10-02 S Sale
2.7
Plassche Douglas

EVP Operations

Officer
76,121 +19.4%
287.48
US$2,606,307 		76,121 +19.4% 287.48 US$2,606,307
2025-08-26 2025-08-22 S Sale
1.5
ELITE PHARMACEUTICALS INC /NV/

EVP Operations

Officer
500,000 -21.7%
0.52
US$262,150 		500,000 -21.7% 0.52 US$262,150
2025-08-22 2025-08-22 PrS Proposed sale
2.7
Plassche Douglas

Officer

Officer
100,000
5.55
US$555,000 		100,000 5.55 US$555,000
2025-07-25 2025-07-10 B Purchase
2.2
Kirkov Kirko

Chief Commercial Officer

Officer
16,366 +inf%
0.59
US$9,640 		16,366 +inf% 0.59 US$9,640
2025-07-10 2025-07-08 S Sale
2.7
Plassche Douglas

EVP Operations

Officer
200,000 -8.0%
0.58
US$115,800 		200,000 -8.0% 0.58 US$115,800
2025-07-08 2025-07-08 PrS Proposed sale
2.7
Plassche Douglas

Officer

Officer
500,000
0.61
US$303,000 		500,000 0.61 US$303,000
2024-10-28 2024-10-24 S Sale
2.7
Plassche Douglas

SVP of Operations

Officer
333,932 -100.0%
0.51
US$170,305 		333,932 -100.0% 0.51 US$170,305
2024-10-28 2024-10-23 S Sale
2.7
Plassche Douglas

SVP of Operations

Officer
800,000 -70.6%
0.49
US$392,000 		800,000 -70.6% 0.49 US$392,000
2024-10-23 2024-10-23 PrS Proposed sale
2.7
Plassche Douglas

Officer

Officer
1,133,932
0.60
US$680,359 		1,133,932 0.60 US$680,359
2016-03-21 2016-03-18 S Sale TREPPEL JERRY

former Chairman
258,090 -3.3%
0.34
US$88,267 		258,090 -3.3% 0.34 US$88,267
2016-03-21 2016-03-17 S Sale TREPPEL JERRY

former Chairman
312,430 -3.8%
0.35
US$107,788 		312,430 -3.8% 0.35 US$107,788
2016-02-24 2016-02-24 S Sale TREPPEL JERRY

former Chairman
100,456 -1.2%
0.31
US$31,141 		100,456 -1.2% 0.31 US$31,141
2016-02-24 2016-02-22 S Sale TREPPEL JERRY

former Chairman
100,000 -1.2%
0.32
US$32,090 		100,000 -1.2% 0.32 US$32,090
2016-02-18 2016-02-17 S Sale TREPPEL JERRY

former Chairman
50,000 -0.6%
0.31
US$15,580 		50,000 -0.6% 0.31 US$15,580
2016-02-18 2016-02-05 S Sale TREPPEL JERRY

former Chairman
24,400 -0.3%
0.33
US$8,052 		24,400 -0.3% 0.33 US$8,052
2016-02-18 2016-02-04 S Sale TREPPEL JERRY

former Chairman
349,660 -4.0%
0.32
US$111,891 		349,660 -4.0% 0.32 US$111,891
2016-02-18 2016-02-03 S Sale TREPPEL JERRY

former Chairman
45,518 -0.5%
0.33
US$15,021 		45,518 -0.5% 0.33 US$15,021
2016-02-18 2016-02-02 S Sale TREPPEL JERRY

former Chairman
13,000 -0.1%
0.33
US$4,290 		13,000 -0.1% 0.33 US$4,290
2016-02-18 2016-02-01 S Sale TREPPEL JERRY

former Chairman
312,300 -3.4%
0.34
US$106,182 		312,300 -3.4% 0.34 US$106,182
2016-02-18 2016-01-29 S Sale TREPPEL JERRY

former Chairman
115,000 -1.3%
0.35
US$40,250 		115,000 -1.3% 0.35 US$40,250
2015-11-18 2015-11-18 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
25,000 -0.3%
0.31
US$7,625 		25,000 -0.3% 0.31 US$7,625
2015-11-18 2015-11-17 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
25,000 -0.3%
0.30
US$7,502 		25,000 -0.3% 0.30 US$7,502
2015-11-18 2015-11-16 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
50,000 -0.5%
0.30
US$15,125 		50,000 -0.5% 0.30 US$15,125
2015-11-18 2015-11-13 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
50,000 -0.5%
0.30
US$15,000 		50,000 -0.5% 0.30 US$15,000
2015-04-28 2015-04-27 S Sale Plassche Douglas

Executive VP of Operations

Officer
85,530 -53.9%
0.24
US$20,168 		85,530 -53.9% 0.24 US$20,168
2014-09-29 2014-09-26 B Purchase Hakim Nasrat A

CEO & President

Executive Director
265,500 +10.9%
0.31
US$82,385 		265,500 +10.9% 0.31 US$82,385
2014-09-29 2014-09-25 B Purchase Hakim Nasrat A

CEO & President

Executive Director
434,500 +21.7%
0.31
US$133,956 		434,500 +21.7% 0.31 US$133,956
2014-05-13 2014-05-09 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
329,437 -5.6%
0.38
US$125,944 		329,437 -5.6% 0.38 US$125,944
2014-04-04 2014-04-02 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
147,664 -2.5%
0.41
US$60,542 		147,664 -2.5% 0.41 US$60,542
2014-03-31 2014-03-27 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
190,172 -3.1%
0.43
US$81,165 		190,172 -3.1% 0.43 US$81,165
2014-03-17 2014-03-11 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
239,367 -1.2%
0.60
US$144,003 		239,367 -1.2% 0.60 US$144,003
2014-03-17 2014-03-11 S Sale EPIC PHARMA LLC Large shareholder
239,367 -0.4%
0.60
US$144,003 		239,367 -0.4% 0.60 US$144,003
2014-03-17 2014-03-11 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
239,367 -1.6%
0.60
US$144,003 		239,367 -1.6% 0.60 US$144,003
2014-03-17 2014-03-11 S Sale EPIC INVESTMENTS, LLC Large shareholder
239,367 -0.4%
0.60
US$144,003 		239,367 -0.4% 0.60 US$144,003
2014-03-10 2014-03-07 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
1,051,450 -6.6%
0.68
US$714,986 		1,051,450 -6.6% 0.68 US$714,986
2014-03-10 2014-03-07 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
1,051,450 -4.9%
0.68
US$714,986 		1,051,450 -4.9% 0.68 US$714,986
2014-03-10 2014-03-07 S Sale EPIC INVESTMENTS, LLC Large shareholder
1,051,450 -1.5%
0.68
US$714,986 		1,051,450 -1.5% 0.68 US$714,986
2014-03-10 2014-03-07 S Sale EPIC PHARMA LLC Large shareholder
1,051,450 -1.5%
0.68
US$714,986 		1,051,450 -1.5% 0.68 US$714,986
2014-03-10 2014-03-06 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
773,050 -4.8%
0.90
US$692,344 		773,050 -4.8% 0.90 US$692,344
2014-03-10 2014-03-06 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
773,050 -3.6%
0.90
US$692,344 		773,050 -3.6% 0.90 US$692,344
2014-03-10 2014-03-06 S Sale EPIC INVESTMENTS, LLC Large shareholder
773,050 -1.1%
0.90
US$692,344 		773,050 -1.1% 0.90 US$692,344
2014-03-10 2014-03-06 S Sale EPIC PHARMA LLC Large shareholder
773,050 -1.1%
0.90
US$692,344 		773,050 -1.1% 0.90 US$692,344
2014-01-17 2014-01-13 S Sale EPIC PHARMA LLC Large shareholder
805,583 -1.1%
0.18
US$147,422 		805,583 -1.1% 0.18 US$147,422
2014-01-17 2014-01-13 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
805,583 -5.0%
0.18
US$147,422 		805,583 -5.0% 0.18 US$147,422
2014-01-17 2014-01-13 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
805,583 -3.7%
0.18
US$147,422 		805,583 -3.7% 0.18 US$147,422
2014-01-17 2014-01-13 S Sale EPIC INVESTMENTS, LLC Large shareholder
805,538 -1.1%
0.18
US$147,413 		805,538 -1.1% 0.18 US$147,413
2013-12-16 2013-12-05 S Sale EPIC INVESTMENTS, LLC Large shareholder
275,000 -0.4%
0.13
US$34,512 		275,000 -0.4% 0.13 US$34,512
2013-12-13 2013-12-05 S Sale EPIC PHARMA LLC Large shareholder
275,000 -0.4%
0.13
US$34,512 		275,000 -0.4% 0.13 US$34,512
2013-12-13 2013-12-05 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
275,000 -1.7%
0.13
US$34,512 		275,000 -1.7% 0.13 US$34,512
2013-12-13 2013-12-05 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
275,000 -1.3%
0.13
US$34,512 		275,000 -1.3% 0.13 US$34,512
2013-12-04 2013-12-02 S Sale EPIC PHARMA LLC Large shareholder
100,000 -0.1%
0.13
US$12,520 		100,000 -0.1% 0.13 US$12,520
2013-12-04 2013-12-02 S Sale EPIC INVESTMENTS, LLC Large shareholder
100,000 -0.1%
0.13
US$12,520 		100,000 -0.1% 0.13 US$12,520
2013-12-04 2013-12-02 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
100,000 -0.5%
0.13
US$12,520 		100,000 -0.5% 0.13 US$12,520
2013-11-29 2013-11-27 S Sale EPIC INVESTMENTS, LLC Large shareholder
25,000 -0.0%
0.12
US$3,030 		25,000 -0.0% 0.12 US$3,030
2013-11-29 2013-11-27 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
25,000 -0.1%
0.12
US$3,030 		25,000 -0.1% 0.12 US$3,030
2013-11-29 2013-11-27 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
25,000 -0.2%
0.12
US$3,030 		25,000 -0.2% 0.12 US$3,030
2013-11-29 2013-11-27 S Sale EPIC PHARMA LLC Large shareholder
25,000 -0.0%
0.12
US$3,030 		25,000 -0.0% 0.12 US$3,030
2013-12-16 2013-11-26 S Sale EPIC INVESTMENTS, LLC Large shareholder
23,626 -0.0%
0.12
US$2,793 		23,626 -0.0% 0.12 US$2,793
2013-12-13 2013-11-26 S Sale EPIC PHARMA LLC Large shareholder
23,626 -0.0%
0.12
US$2,793 		23,626 -0.0% 0.12 US$2,793
2013-12-13 2013-11-26 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
23,626 -0.2%
0.12
US$2,793 		23,626 -0.2% 0.12 US$2,793
2013-12-13 2013-11-26 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
23,626 -0.1%
0.12
US$2,793 		23,626 -0.1% 0.12 US$2,793
2013-11-29 2013-11-26 S Sale EPIC INVESTMENTS, LLC Large shareholder
357,000 -0.5%
0.12
US$43,126 		357,000 -0.5% 0.12 US$43,126
2013-11-29 2013-11-26 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
357,000 -1.6%
0.12
US$43,126 		357,000 -1.6% 0.12 US$43,126
2013-11-29 2013-11-26 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
357,000 -2.2%
0.12
US$43,126 		357,000 -2.2% 0.12 US$43,126
2013-11-29 2013-11-26 S Sale EPIC PHARMA LLC Large shareholder
357,000 -0.5%
0.12
US$43,126 		357,000 -0.5% 0.12 US$43,126
2013-11-19 2013-11-19 S Sale EPIC INVESTMENTS, LLC Large shareholder
21,000 -0.0%
0.12
US$2,457 		21,000 -0.0% 0.12 US$2,457
2013-11-19 2013-11-19 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
21,000 -0.1%
0.12
US$2,499 		21,000 -0.1% 0.12 US$2,499
2013-11-19 2013-11-19 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
21,000 -0.1%
0.12
US$2,457 		21,000 -0.1% 0.12 US$2,457
2013-11-19 2013-11-19 S Sale EPIC PHARMA LLC Large shareholder
21,000 -0.0%
0.12
US$2,457 		21,000 -0.0% 0.12 US$2,457
2013-11-19 2013-11-18 S Sale EPIC INVESTMENTS, LLC Large shareholder
1,170,000 -1.6%
0.12
US$137,475 		1,170,000 -1.6% 0.12 US$137,475
2013-11-19 2013-11-18 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
1,170,000 -6.9%
0.12
US$137,475 		1,170,000 -6.9% 0.12 US$137,475
2013-11-19 2013-11-18 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
1,170,000 -5.1%
0.12
US$137,475 		1,170,000 -5.1% 0.12 US$137,475
2013-11-19 2013-11-18 S Sale EPIC PHARMA LLC Large shareholder
1,170,000 -1.6%
0.12
US$137,475 		1,170,000 -1.6% 0.12 US$137,475
Explore more

More insider trading research around Elite Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America